Benjamin Burnett
Stock Analyst at Stifel
(1.57)
# 3,253
Out of 4,876 analysts
68
Total ratings
39.58%
Success rate
-7.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FATE Fate Therapeutics | Maintains: Hold | $5 → $3 | $1.10 | +172.73% | 3 | Mar 6, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Hold | $53 → $49 | $46.70 | +4.93% | 6 | Feb 13, 2025 | |
| ACLX Arcellx | Maintains: Buy | $83 → $122 | $64.77 | +88.36% | 5 | Oct 18, 2024 | |
| BEAM Beam Therapeutics | Maintains: Buy | $66 → $69 | $17.14 | +302.57% | 2 | Sep 11, 2024 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $63 → $68 | $22.29 | +205.07% | 7 | Sep 10, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Hold | $4.4 → $4.6 | $1.20 | +283.33% | 5 | May 14, 2024 | |
| ATRA Atara Biotherapeutics | Maintains: Hold | $120 → $58 | $7.95 | +623.27% | 4 | Apr 1, 2024 | |
| DTIL Precision BioSciences | Maintains: Buy | $690 → $780 | $4.14 | +18,740.58% | 2 | Sep 10, 2021 | |
| RVMD Revolution Medicines | Maintains: Buy | $78 → $64 | $37.48 | +70.76% | 5 | Apr 1, 2025 | |
| IRON Disc Medicine | Maintains: Buy | $90 → $94 | $54.13 | +73.66% | 7 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $4 | $1.40 | +185.71% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.43 | +599.30% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.74 | +1,336.78% | 11 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $330 → $360 | $29.68 | +1,112.94% | 2 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $16 | $0.56 | +2,770.99% | 1 | Jan 6, 2021 |
Fate Therapeutics
Mar 6, 2025
Maintains: Hold
Price Target: $5 → $3
Current: $1.10
Upside: +172.73%
CRISPR Therapeutics AG
Feb 13, 2025
Maintains: Hold
Price Target: $53 → $49
Current: $46.70
Upside: +4.93%
Arcellx
Oct 18, 2024
Maintains: Buy
Price Target: $83 → $122
Current: $64.77
Upside: +88.36%
Beam Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $66 → $69
Current: $17.14
Upside: +302.57%
IDEAYA Biosciences
Sep 10, 2024
Maintains: Buy
Price Target: $63 → $68
Current: $22.29
Upside: +205.07%
Allogene Therapeutics
May 14, 2024
Maintains: Hold
Price Target: $4.4 → $4.6
Current: $1.20
Upside: +283.33%
Atara Biotherapeutics
Apr 1, 2024
Maintains: Hold
Price Target: $120 → $58
Current: $7.95
Upside: +623.27%
Precision BioSciences
Sep 10, 2021
Maintains: Buy
Price Target: $690 → $780
Current: $4.14
Upside: +18,740.58%
Revolution Medicines
Apr 1, 2025
Maintains: Buy
Price Target: $78 → $64
Current: $37.48
Upside: +70.76%
Disc Medicine
Jan 24, 2025
Maintains: Buy
Price Target: $90 → $94
Current: $54.13
Upside: +73.66%
Dec 13, 2024
Maintains: Buy
Price Target: $9 → $4
Current: $1.40
Upside: +185.71%
Jun 3, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.43
Upside: +599.30%
Sep 15, 2023
Reiterates: Buy
Price Target: $25
Current: $1.74
Upside: +1,336.78%
Jun 28, 2021
Upgrades: Buy
Price Target: $330 → $360
Current: $29.68
Upside: +1,112.94%
Jan 6, 2021
Initiates: Hold
Price Target: $16
Current: $0.56
Upside: +2,770.99%